Ovulation Induction

Ovulation induction is a medical process aimed at stimulating the ovulation cycle and increasing the number of available eggs through specific medications. This procedure targets women with low conception probabilities by using hormonal drugs to enhance the production and release of eggs.

Infertility is a condition that affects both men and women equally. In women with irregular menstrual cycles, predicting the exact timing of ovulation can be challenging. If the eggs within the ovaries do not reach sufficient maturity or are not released into the fallopian tubes, pregnancy cannot occur. Approximately 30% of female infertility cases are related to ovulation disorders. Ovulation induction, often referred to as “egg development therapy,” is one of the most common treatments used to overcome these issues.

The Normal Ovulatory Cycle

In a standard ovulatory system, the ovaries release one mature egg per cycle for fertilization. This process typically occurs every 28 days during the menstrual cycle. A cycle length between 21 and 35 days is considered normal. If fertilization does not occur during this window, the egg and uterine tissues are shed through menstruation.

When ovulation occurs less than once every 35 days or becomes unpredictable, it is considered irregular. This irregularity negatively impacts fertility as the “fertile window” cannot be determined. In such cases, ovulation induction can resolve the issue by regulating the cycle.

Who is Eligible for Ovulation Induction?

Egg development therapy is primarily preferred for women who experience absent (anovulation) or infrequent (oligovulation) ovulation cycles.

Key indications for Ovulation Induction include:

• Polycystic Ovary Syndrome (PCOS): A common cause of infertility where eggs do not develop properly or are not released normally. PCOS is often accompanied by unexplained weight gain, hirsutism (excessive body/facial hair), hair loss, and irregular periods.

• Hypothalamic Dysfunction: Disruptions in the hypothalamus that negatively affect the egg production signaling system.

• Premature Ovarian Failure: When egg production stops significantly before the typical age of menopause.

• Indirect Factors Affecting Ovulation: This includes thyroid disorders, extreme stress, eating disorders, excessive exercise, and obesity.

• Assisted Reproduction Prep: It is commonly used as a preliminary step before Intrauterine Insemination (IUI) or In Vitro Fertilization (IVF).

How is Ovulation Induction Performed?

Before treating ovulation problems, the underlying cause must be identified. Specialists perform a series of tests and examinations, including blood tests for Thyroid, FSH, LH, Testosterone, Androgens, and Prolactin, along with detailed ultrasound scans of the ovaries and uterus. These evaluations determine how the ovaries will respond to medication.

The ovulation induction method allows for the controlled stimulation of the ovaries, the maturation of an egg, and its eventual release. In women with irregular cycles, follicle tracking and hormonal assessments are conducted regularly throughout the treatment. This enables the specialist to pinpoint the exact fertile window.

Once the eggs reach a specific size, a “trigger shot” is administered. Following this injection:

• Timed Intercourse: Typically recommended 36 hours after the shot.

• Assisted Reproduction: Alternatively, egg retrieval is performed for procedures such as IUI, IVF, or ICSI.

Due to the regular monitoring involved, the probability of achieving a successful pregnancy is significantly higher.

Medications Used in Ovulation Induction

The primary focus of drug therapy is to trigger ovulation in cases of dysfunction, regulate the ovulatory cycle, and increase the number of available eggs to improve pregnancy odds. Dosages and combinations are strictly personalized by the specialist.

Frequently Used Medications:

• Human Menopausal Gonadotropin (hMG): Composed of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). Administered via injection, it is typically used for women who do not ovulate naturally or have highly irregular cycles.

• Follicle-Stimulating Hormone (FSH): These injectable drugs facilitate the recruitment and development of eggs. Detailed monitoring via ultrasound and blood estrogen tests is required during these cycles.

• Human Chorionic Gonadotropin (hCG): Known as the “trigger shot,” this natural hormone triggers the final maturation and release of the eggs. Ovulation generally begins 36 hours after hCG administration.

• GnRH Agonists/Antagonists (e.g., Lupron): These synthetic inhibitors suppress the brain’s natural release of LH and FSH. This prevents premature ovulation and ensures that multiple follicles develop simultaneously and healthily.

Does Ovulation Induction Cause Early Menopause?

There is no scientific link between ovulation induction medications and early menopause.

In a natural cycle, approximately 50 follicles start to grow each month, but only one reaches full maturity while the others naturally regress (atrophy). Ovulation induction simply provides the hormonal support needed for some of those “destined to regress” follicles to continue growing to maturity. It does not deplete the overall ovarian reserve faster than nature intended.

Success and Outcomes

The success rate for achieving pregnancy through egg development therapy is high. Under the guidance of an expert at the right time, prospective mothers can produce high-quality eggs suitable for fertilization, leading to successful reproductive outcomes.